Hepatosplenic .GAMMA..DELTA.T-cell Lymphoma: Report of a Case.

M. Yamaguchi, T. Ohno, N. Takakura, K. Ohishi, K. Oka, K. Nishii, K. Kita, S. Shirakawa
{"title":"Hepatosplenic .GAMMA..DELTA.T-cell Lymphoma: Report of a Case.","authors":"M. Yamaguchi, T. Ohno, N. Takakura, K. Ohishi, K. Oka, K. Nishii, K. Kita, S. Shirakawa","doi":"10.3960/JSLRT1961.33.209","DOIUrl":null,"url":null,"abstract":"A case of γδ T-cell lymphoma with severe hepatosplenomegaly was reported. A 17-year-old male was admitted to the Mie university hospital in Nov., 1991, because of jaundice and hepatosplenomegaly. Neither lymphadenopathy nor skin rush was detected. Laboratory data showed mild anemia, thrombocytopenia, and elevated serum lactate dehydrogenase (LDH) level (1338IU). Leucocyte count was 4790/μl with no abnormal finding. Bone marrow aspiration showed that nucleated cell count was 22.9×104/μl with 52.8% abnormal cells. The cells were large and had irregular nuclei and abundant cytoplasm without azulophilic granule. Their phenotype was CD3+ CD4- CD8- WT31- TCRδ1+ TdT-. DNA analysis of bone marrow mononuclear cells revealed rearrangements of T-cell receptor (TCR) γ and δ chain genes, and germline configulation in TCRβ chain gene and immunoglobulin heavy chain gene. He was diagnosed as γδ T-cell lymphoma (clinical stage IV B), and was first treated with combination therapy of CHOP and granulocyte-colony stimulating factor (G-CSF). The hepatosplenomegaly slightly regressed, but the abnormal cells in bone marrow did not decreased. The therapy was switched to one with carboplatin, ifosfamide, etoposide, and dexamethasone. The hepatosplenomegaly disappeared and the abnormal findings of bone marrow returned to normal. He is alive with partial response disease 7 months after the diagnosis.","PeriodicalId":237003,"journal":{"name":"Journal of the Japan Society of the Reticuloendothelial System","volume":"41 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Japan Society of the Reticuloendothelial System","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3960/JSLRT1961.33.209","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

A case of γδ T-cell lymphoma with severe hepatosplenomegaly was reported. A 17-year-old male was admitted to the Mie university hospital in Nov., 1991, because of jaundice and hepatosplenomegaly. Neither lymphadenopathy nor skin rush was detected. Laboratory data showed mild anemia, thrombocytopenia, and elevated serum lactate dehydrogenase (LDH) level (1338IU). Leucocyte count was 4790/μl with no abnormal finding. Bone marrow aspiration showed that nucleated cell count was 22.9×104/μl with 52.8% abnormal cells. The cells were large and had irregular nuclei and abundant cytoplasm without azulophilic granule. Their phenotype was CD3+ CD4- CD8- WT31- TCRδ1+ TdT-. DNA analysis of bone marrow mononuclear cells revealed rearrangements of T-cell receptor (TCR) γ and δ chain genes, and germline configulation in TCRβ chain gene and immunoglobulin heavy chain gene. He was diagnosed as γδ T-cell lymphoma (clinical stage IV B), and was first treated with combination therapy of CHOP and granulocyte-colony stimulating factor (G-CSF). The hepatosplenomegaly slightly regressed, but the abnormal cells in bone marrow did not decreased. The therapy was switched to one with carboplatin, ifosfamide, etoposide, and dexamethasone. The hepatosplenomegaly disappeared and the abnormal findings of bone marrow returned to normal. He is alive with partial response disease 7 months after the diagnosis.
Hepatosplenic可以. .δ。t细胞淋巴瘤1例报告。
本文报告1例γδ t细胞淋巴瘤合并严重肝脾肿大。1991年11月,一名17岁男性因黄疸和肝脾肿大被送入Mie大学医院。未发现淋巴结病或皮肤过敏。实验室数据显示轻度贫血,血小板减少,血清乳酸脱氢酶(LDH)水平升高(1338IU)。白细胞计数4790/μl,未见异常。骨髓穿刺显示有核细胞计数22.9×104/μl,异常细胞占52.8%。细胞体积大,细胞核不规则,胞质丰富,无亲氮颗粒。其表型为CD3+ CD4- CD8- WT31- TCRδ1+ TdT-。骨髓单核细胞DNA分析显示t细胞受体(TCR) γ链和δ链基因重排,TCRβ链基因和免疫球蛋白重链基因存在种系构型。患者被诊断为γδ t细胞淋巴瘤(临床IV期B),首次接受CHOP联合粒细胞集落刺激因子(G-CSF)治疗。肝脾肿大轻微消退,但骨髓异常细胞未减少。治疗转为卡铂、异环磷酰胺、依托泊苷和地塞米松联合治疗。肝脾肿大消失,骨髓异常恢复正常。他在诊断后7个月患有部分反应性疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信